$44.5 - EXEL | Exelixis Inc

Exelixis Inc (EXEL)

Exelixis Inc

XNAS:EXEL

44.5

0.29%

Ask

$47.48 - 5.00

Bid

$24.32 - 11.00

Low

$43.85

High

$44.59

Open

$44.2

Prev Close

$44.37

52W High

49.62

52W Low

31.9

Volume

2193725

Avg Vol (3m)

2553177.9

Float

259675051.58

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2836

Sector: Health Technology

Industry: Pharmaceuticals: Major

Date Listed: 04/11/2000

Primary Exchange: XNAS

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Phone: (650) 837-7000

Address: 1851 Harbor Bay Parkway

City: Alameda

State: CA

Postal Code: 94502

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

1,147

P/E (TTM)

18.679746

P/B (TTM)

5.505390

Round Lot

100

Composit FIGI

BBG000BQ4WF8

Share Class FIGI

BBG001SD42W4

Share Class Shares Outstanding

269.20M

Weighted Shares Outstanding

268.11M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion